Kok Pin Ng1,2,3, Stéphane Richard-Devantoy4,5, Josie-Anne Bertrand6, Lai Jiang7,8, Tharick A Pascoal1,3, Sulantha Mathotaarachchi1,3, Joseph Therriault1,3, Chathuri Yatawara2, Nagaendran Kandiah2, Celia M T Greenwood7,8, Pedro Rosa-Neto1,3, Serge Gauthier1,3. 1. Alzheimer's Disease Research Unit, McGill Centre for Studies in Aging, McGill University, Québec, Canada. 2. Department of Neurology, National Neuroscience Institute, Singapore. 3. Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, Québec, Canada. 4. Department of Psychiatry & Douglas Mental Health University Institute, McGill Group for Suicide Studies, McGill University, Québec, Montréal, Canada. 5. CISSS des Laurentides, Quebec, Canada. 6. Douglas Research Center, Douglas Mental Health University Institute, Québec, Canada. 7. Lady Davis Institute, McGill University, Québec, Canada. 8. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Québec, Canada.
Abstract
OBJECTIVES: To study the frequency of suicidal ideation and its association with clinical and neurobiological correlates among cognitively intact autosomal dominant Alzheimer's disease (ADAD) at-risk individuals. METHODS/ DESIGN: In a cross-sectional study of 183 ADAD at-risk individuals (91 mutation carriers and 92 noncarriers), we compared the frequency of suicidal ideation among carriers and noncarriers. Linear mixed-effects models with family-level random effects evaluated the relationships between geriatric depression scale (GDS), neuropsychiatric inventory-questionnaire (NPI-Q), and suicidal ideation scores among all ADAD at-risk individuals. An interaction term was added to the regression models to evaluate the interactions of suicidal ideation and mutation status on neuropsychiatric symptoms. RESULTS: Twenty-six (14.20%) ADAD at-risk individuals (13 [14.28%] carriers and 13 [14.13%] noncarriers) had suicidal ideation. The frequency of suicidal ideation did not differ between carriers and noncarriers. Suicidal ideation was associated with higher GDS among all ADAD at-risk individuals. When stratified into mutation carrier status, noncarriers with suicidal ideation had higher GDS than carriers. There was no statistically significant association between suicidal ideation and NPI-Q among ADAD at-risk individuals. Awareness of mutation status, neuropsychological performances, and cerebrospinal fluid AD biomarkers were not associated with suicidal ideation among carriers and noncarriers. CONCLUSIONS: Suicidal ideation is common among cognitively intact ADAD at-risk individuals. While ADAD at-risk individuals with suicidal ideation have greater depressive symptoms, noncarriers with suicidal ideation have higher GDS scores than carriers. Interestingly, awareness of the mutation status was not associated with suicidal ideation in our study. Early identification of suicidal thoughts can facilitate timely interventions to prevent suicidal behaviours. Keywords autosomal dominant Alzheimer's diseasedominantly inherited Alzheimer's networkneuropsychiatric symptomssuicidal ideation.
OBJECTIVES: To study the frequency of suicidal ideation and its association with clinical and neurobiological correlates among cognitively intact autosomal dominant Alzheimer's disease (ADAD) at-risk individuals. METHODS/ DESIGN: In a cross-sectional study of 183 ADAD at-risk individuals (91 mutation carriers and 92 noncarriers), we compared the frequency of suicidal ideation among carriers and noncarriers. Linear mixed-effects models with family-level random effects evaluated the relationships between geriatric depression scale (GDS), neuropsychiatric inventory-questionnaire (NPI-Q), and suicidal ideation scores among all ADAD at-risk individuals. An interaction term was added to the regression models to evaluate the interactions of suicidal ideation and mutation status on neuropsychiatric symptoms. RESULTS: Twenty-six (14.20%) ADAD at-risk individuals (13 [14.28%] carriers and 13 [14.13%] noncarriers) had suicidal ideation. The frequency of suicidal ideation did not differ between carriers and noncarriers. Suicidal ideation was associated with higher GDS among all ADAD at-risk individuals. When stratified into mutation carrier status, noncarriers with suicidal ideation had higher GDS than carriers. There was no statistically significant association between suicidal ideation and NPI-Q among ADAD at-risk individuals. Awareness of mutation status, neuropsychological performances, and cerebrospinal fluid AD biomarkers were not associated with suicidal ideation among carriers and noncarriers. CONCLUSIONS: Suicidal ideation is common among cognitively intact ADAD at-risk individuals. While ADAD at-risk individuals with suicidal ideation have greater depressive symptoms, noncarriers with suicidal ideation have higher GDS scores than carriers. Interestingly, awareness of the mutation status was not associated with suicidal ideation in our study. Early identification of suicidal thoughts can facilitate timely interventions to prevent suicidal behaviours. Keywords autosomal dominant Alzheimer's diseasedominantly inherited Alzheimer's networkneuropsychiatric symptomssuicidal ideation.
Authors: Xiao-Lan Cao; Bao-Liang Zhong; Yu-Tao Xiang; Gabor S Ungvari; Kelly Y C Lai; Helen F K Chiu; Eric D Caine Journal: Int J Psychiatry Med Date: 2015-06-09 Impact factor: 1.210
Authors: Anne M Fagan; Chengjie Xiong; Mateusz S Jasielec; Randall J Bateman; Alison M Goate; Tammie L S Benzinger; Bernardino Ghetti; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Reisa A Sperling; Daniel Marcus; Nigel J Cairns; Virginia D Buckles; Jack H Ladenson; John C Morris; David M Holtzman Journal: Sci Transl Med Date: 2014-03-05 Impact factor: 17.956
Authors: Anna A M Hubers; Annette Hamming; Erik J Giltay; Margaret von Faber; Raymund A C Roos; Rose C van der Mast; Erik van Duijn Journal: J Huntingtons Dis Date: 2016-05-31
Authors: Joshua D Grill; Randall J Bateman; Virginia Buckles; Angela Oliver; John C Morris; Colin L Masters; William E Klunk; John M Ringman Journal: Alzheimers Res Ther Date: 2015-07-22 Impact factor: 6.982